Vitamin e shows promise in calming COVID-19's inflammatory storm
NCT ID NCT07412574
Summary
This small, early-stage study tested whether giving high doses of vitamin E (an antioxidant) to COVID-19 patients could reduce a key marker of harmful inflammation called C-reactive protein (CRP). Researchers compared CRP levels in 56 adult patients who received either vitamin E or a placebo. The goal was to see if this simple supplement could help control the body's overactive immune response to the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine
Xalapa, Veracruz, 91120, Mexico
Conditions
Explore the condition pages connected to this study.